{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T10:58:20Z","timestamp":1692874700385},"reference-count":9,"publisher":"MDPI AG","issue":"1-4","license":[{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatopathology"],"DOI":"10.1159\/000481309","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T22:01:22Z","timestamp":1510783282000},"page":"13-17","source":"Crossref","is-referenced-by-count":2,"title":["A 65-Year-Old Male with Primary Central Nervous System Diffuse Large B-Cell Lymphoma on Nivolumab with Oral Mucositis and Targetoid Plaques"],"prefix":"10.3390","volume":"4","author":[{"given":"Severine","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooyan","family":"Rohani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalynn M.","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Kroshinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Iwai Y, Hamanishi J, Chamoto K, Honjo T: Cancer immunotherapies targeting the PD-1 signaling pathway. J Biomed Sci 2017;24:26.","DOI":"10.1186\/s12929-017-0329-9"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Naidoo J, Page DB, Li BT, Connell LC, Schindler K, Lacouture ME, Postow MA, Wolchok JD: Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Ann Oncol 2015;26:2375-2391.","DOI":"10.1093\/annonc\/mdv383"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Sanlorenzo M, Vujic I, Daud A, Algazi A, Gubens M, Luna SA, Lin K, Quaglino P, Rappersberger K, Ortiz-Urda S: Pembrolizumab cutaneous adverse events and their association with disease progression. JAMA Dermatol 2015;151:1206-1212.","DOI":"10.1001\/jamadermatol.2015.1916"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Friedman CF, Proverbs-Singh TA, Postow MA: Treatment of the immune-related adverse effects of immune checkpoint inhibitors: a review. JAMA Oncol 2016;2:1346-1353.","DOI":"10.1001\/jamaoncol.2016.1051"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Joseph RW, Cappel M, Goedjen B, Gordon M, Kirsch B, Gilstrap C, Bagaria S, Jambusaria-Pahlajani A: Lichenoid dermatitis in three patients with metastatic melanoma treated with anti-PD-1 therapy. Cancer Immunol Res 2015;3:18-22.","DOI":"10.1158\/2326-6066.CIR-14-0134"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Jour G, Glitza IC, Ellis RM, Torres-Cabala CA, Tetzlaff MT, Li JY, Nagarajan P, Huen A, Aung PP, Ivan D, Drucker CR, Prieto VG, Rapini RP, Patel A, Curry JL: Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions. J Cutan Pathol 2016;43:688-696.","DOI":"10.1111\/cup.12717"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Postow MA: Managing immune checkpoint-blocking antibody side effects. Am Soc Clin Oncol Educ Book 2015;35:76-83.","DOI":"10.14694\/EdBook_AM.2015.35.76"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Brice SL, Krzemien D, Weston WL, Huff JC: Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme. J Invest Dermatol 1989;93:183-187.","DOI":"10.1111\/1523-1747.ep12277397"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Curry JL, Tetzlaff MT, Nagarajan P, Drucker C, Diab A, Hymes SR, Duvic M, Hwu WJ, Wargo JA, Torres-Cabala CA, Rapini RP, Prieto VG: Diverse types of dermatologic toxicities from immune checkpoint blockade therapy. J Cutan Pathol 2017;44:158-176.","DOI":"10.1111\/cup.12858"}],"container-title":["Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/481309","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/481309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T13:46:38Z","timestamp":1591969598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.karger.com\/Article\/FullText\/481309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,16]]},"references-count":9,"journal-issue":{"issue":"1-4","published-online":{"date-parts":[[2018,1,4]]}},"URL":"https:\/\/doi.org\/10.1159\/000481309","archive":["Portico"],"relation":{},"ISSN":["2296-3529"],"issn-type":[{"value":"2296-3529","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,16]]}}}